1. Articles in category: Other Business News

    73-96 of 1008 « 1 2 3 4 5 6 7 ... 40 41 42 »
    1. Santec receives FDA Approval for ARGOS, Advanced Optical Biometer to measure eye parameters of patients before cataract surgery.

      Santec receives FDA Approval for ARGOS, Advanced Optical Biometer to measure eye parameters of patients before cataract surgery.

      Santec, a leading manufacturer of innovative lasers and optical components for fiber-optic telecommunications, sensing, medical and metrology markets announces that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance to market the ARGOS, Advanced Optical Biometer for use in intraocular lens (IOL) selection for patients with cataracts. The ARGOS delivers advantages of high measurement success rates, speed and accuracy to measure 9-essential parameters for IOL selection. The values acquired in less than 1-sec are: Axial Length, Corneal Thickness, Anterior Chamber Depth, Lens Thickness, Pupil Size, Corneal Diameter, K-values (K1, K2), Toric Angle. ARGOS provides a unique ...

      Read Full Article
    2. Compact Imaging Co-founder/CTO Will Present at London Biometrics Conference

      Compact Imaging Co-founder/CTO Will Present at London Biometrics Conference

      At the upcoming Biometrics 2015 Conference in London, Dr. Josh Hogan, CTO and co-founder of Compact Imaging (CI), a Silicon Valley-based technology company developing miniature, low cost optical sensors, will present the Company’s approach to strengthening fingerprint authentication systems by offering a practical means to provide highly secure sub-dermal fingerprint images and information. At the conference, scheduled for Oct. 13-15, Dr. Hogan will describe Compact Imaging’s proprietary Multiple Reference OCT (MRO™) system, which makes optical coherence tomography (OCT) imaging technology practical for fingerprint authentication applications. OCT uses light to scan noninvasively below the skin surface to provide depth ...

      Read Full Article
    3. Santec receives FDA Approval for ARGOS, Advanced Optical Biometer to measure eye parameters of patients before cataract surgery.

      Santec receives FDA Approval for ARGOS, Advanced Optical Biometer to measure eye parameters of patients before cataract surgery.

      Santec, a leading manufacturer of innovative lasers and optical components for fiber-optic telecommunications, sensing, medical and metrology markets announces that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance to market the ARGOS, Advanced Optical Biometer for use in intraocular lens (IOL) selection for patients with cataracts. The ARGOS delivers advantages of high measurement success rates, speed and accuracy to measure 9-essential parameters for IOL selection. The values acquired in less than 1-sec are: Axial Length, Corneal Thickness, Anterior Chamber Depth, Lens Thickness, Pupil Size, Corneal Diameter, K-values (K1, K2), Toric Angle. ARGOS provides a unique ...

      Read Full Article
    4. Compact Imaging Granted 15th Patent for Miniature, Low-Cost OCT Technology

      Compact Imaging Granted 15th Patent for Miniature, Low-Cost OCT Technology

      Compact Imaging, Inc. (CI), a Silicon Valley technology company developing miniature, low-cost optical sensors for the rapidly growing biometric security, mobile personal health monitoring and non-destructive testing (NDT) markets, today announced that it had been granted an additional US patent. The new patent increases the CI intellectual property (IP) portfolio to 15 US patents and an equal number of pending US and foreign applications. The Company’s IP centers on multiple-reference optical coherence tomography (MRO™), CI’s miniature version of optical coherence tomography (OCT). A well-established, non-invasive, non-ionizing imaging technology, OCT is widely used in clinical diagnostic applications. Compact Imaging ...

      Read Full Article
    5. MedLumics Technology Validated for Real-time Assessment of Catheter Ablation Treatment of Atrial Fibrillation in Pre-clinical Feasibility Study

      MedLumics Technology Validated for Real-time Assessment of Catheter Ablation Treatment of Atrial Fibrillation in Pre-clinical Feasibility Study

      MedLumics, a medical imaging company specializing in advanced optical coherence tomography (OCT) technology, has announced the completion of a successful single-case pre-clinical feasibility study of its technology in the catheter ablation treatment of atrial fibrillation (AF). The study incorporated a novel catheter capable of simultaneous radiofrequency ablation and imaging based on MedLumics’ polarization-sensitive optical coherence reflectometry and showed that the combined technology may help improve clinical outcomes by providing direct, real-time information on ablation efficacy. 1 Results of the study were published in the August issue of The Journal of Innovations in Cardiac Rhythm Management. “These promising results show the ...

      Read Full Article
    6. Moptim launched the MOcean 3000 SLO OCT at 2015 ESCRS Barcelona

      Moptim launched the MOcean 3000 SLO OCT at 2015 ESCRS Barcelona

      XXXIII Congress of the ESCRS was held in Barcelona, Spain from 5 - 9 Sept. 2015, having attracted more than 5000 ophthalmologists and hundreds of exhibitors from all over the world. At the conference, Moptim introduced the new Optical Coherence Tomography (OCT) MOcean 3000/3000 Plus, a high definition wide range OCT and SLO combined system which is proudly designed and manufactured in China. The MOcean 3000 is an ideal choice for first-time OCT users. It offers powerful analysis functions including retina, anterior segment analysis, and comprehensive glaucoma analysis. Moreover, the streamline user interface creates an excellent user experience.

      Read Full Article
    7. Six-dimensional optical multilayer storage using two-photon absorption writing, erasing and optical coherence tomography reading

      Six-dimensional optical multilayer storage using two-photon absorption writing, erasing and optical coherence tomography reading

      This invention relates a method of six-dimensional optical multilayer storage using two-photon absorption writing, erasing and optical coherence tomography reading and the apparatus designed based on this method. The invented system stores data in three spatial dimensions plus three physical dimensions of wavelength, intensity and polarization. It has large storage capacity of over 32 Tbytes per DVD sized disk and ultrafast reading speed of over 25 Gbits/s with high signal-to-noise ratio of over 76 dB. The larger capacity of over 1 Pbyte per disk is potential. Furthermore, the invented system has relatively simple optical structure, easy light manipulation for ...

      Read Full Article
    8. Optovue Showcases Retinal Blood Flow Measurement Capability for Improving Management of Diabetes-Related Vision Loss

      Optovue Showcases Retinal Blood Flow Measurement Capability for Improving Management of Diabetes-Related Vision Loss

      AngioAnalytics, World’s First OCT Angiography Quantification Technology, Announced at Prestigious European Society for Cataract and Refractive Surgery Optovue, the global leader in the development and commercialization of optical coherence tomography angiography (OCTA), today announced AngioAnalytics™, a significant expansion of its OCTA technology, at the 33rd congress of the European Society for Cataract and Refractive Surgery (ESCRS) being held in Barcelona, Spain from September 5-9. This new capability will provide clinicians with the ability to quantify the density of blood flow in the retina, the light-sensitive portion of the eye. “For the first time ever, ophthalmologists will have the ability ...

      Read Full Article
    9. New cataract and refractive imaging platform to be unveiled by Heidelberg Engineering at European Society of Cataract and Refractive Surgery

      New cataract and refractive imaging platform to be unveiled by Heidelberg Engineering at European Society of Cataract and Refractive Surgery

      Heidelberg Engineering will offer a preview of its cataract and refractive imaging platform* during this year’s Congress of the European Society of Cataract and Refractive Surgery (ESCRS) in Barcelona. The platform is based on an upgradable, modular design, which allows configuration to each product to the specific diagnostic workflow in a practice or clinic. Main options include: IOL biometry, corneal topography/tomography, anterior segment biometry and anterior segment imaging. The new platform is based on swept-source OCT technology. An important characteristic of the new platform is the fact that all measurements and analysis are based on high-resolution diagnostic images ...

      Read Full Article
    10. ZEISS Sets the Pace in OCT Innovation with First FDA 510(k) Clearance of OCT Angiography Technology

      ZEISS Sets the Pace in OCT Innovation with First FDA 510(k) Clearance of OCT Angiography Technology

      D ZEISS Medical Technology announces that its AngioPlex OCT Angiography is the first such technology to receive 510(k) clearance from the U.S. Food and Drug Administration (FDA). “OCT angiography ushers in a new era in the evaluation of the retina in diabetic retinopathy and macular degeneration” With a single additional OCT scan that takes just seconds on the CIRRUS HD-OCT system from ZEISS, ophthalmologists can now utilize optical coherence tomography (OCT) images to assess the blood vessels (vasculature) of the retina at a depth and clarity never available before. AngioPlex OCT Angiography delivers high-resolution, depth-resolved visualization of the ...

      Read Full Article
    11. Swept-Source OCT: Patent License Agreement between Massachusetts General Hospital and Heidelberg Engineering

      Swept-Source OCT: Patent License Agreement between Massachusetts General Hospital and Heidelberg Engineering

      Heidelberg Engineering has entered into a patent license agreement with Massachusetts General Hospital (MGH) in Boston. The agreement grants global and exclusive rights to 77 basic patents and patent applications which relate to swept-source OCT technology and its application in ophthalmology. Spectral domain OCT has become indispensable to eye care professionals worldwide to diagnose and follow-up patients with diseases of the posterior segment of the eye, such as age-related macular degeneration, diabetic retinopathy, or glaucoma. Swept-source OCT technology has specific characteristics which are ideal to acquire comprehensive information about a wide variety of properties of the anterior part of the ...

      Read Full Article
    12. Optovue announces 300 AngioVue systems installed outside the US

      Optovue announces 300 AngioVue systems installed outside the US

      Haag-Streit UK (HS-UK), UK distributor of the Optovue OCT product portfolio, is pleased to announce that Optovue recently installed its 300th AngioVue OCT-A system outside of the United States. After a successful introduction of the revolutionary AngioVue imaging system at the ESCRS meeting in London in September 2014, Universities, hospitals and private clinics are eagerly adopting the technology. Many of the sales include recent installations into UK hospitals. The AngioVue imaging system is a non-invasive, dyeless technique for visualising the presence of ocular flow in the vessels. AngioVue allows clinicians to assess microvasculature and perfusion in ocular diseases with unprecedented ...

      Read Full Article
    13. Rowe Technical Design, Inc. announces that Whole Model Eye for OCT (Tissue Phantom) is now in production!

      Rowe Technical Design, Inc. announces that Whole Model Eye for OCT (Tissue Phantom) is now in production!

      Rowe Technical Design, Inc. (RTD), developers of the 1st commercial optical tissue phantom for OCT, announces that their latest version of the Whole Model Eye complete with Cornea, Crystalline Lens and Retina tissue phantoms for OCT has now been released for full serial production. “We’re excited because this is our third serial production model eye, following up on the very successful anterior chamber and OCT model eyes with retina tissue phantom” notes T. Scott Rowe, company founder and president. “We are extremely pleased with the customer feedback so far, and we are ready for serial production. This is the ...

      Read Full Article
      Mentions: T. Scott Rowe
    14. Acquisition of Spin-out Company Bioptigen to Bring Duke Imaging Technology to New Markets

      Acquisition of Spin-out Company Bioptigen to Bring Duke Imaging Technology to New Markets

      In June 2015, microscopy and imaging systems company Leica Microsystems acquired Bioptigen Inc., a company born from Duke's Pratt School of Engineering. Formed in 2004, Bioptigen has become a leader in optical coherence tomography (OCT), an imaging technique that uses light to capture extremely high-resolution, three-dimensional pictures of the eye. Bioptigen was the brainchild of Duke’s Michael J. Fitzpatrick Professor of Engineering Joseph Izatt and CEO Eric Buckland. Since its launch, the company secured more than 60 issued patents in OCT technology, many of which were licensed from intellectual property developed by Izatt, his students, and collaborators at ...

      Read Full Article
    15. Perimeter Medical Imaging Closes Oversubscribed $5 Million Series A Financing Round Led By Roadmap Capital

      Perimeter Medical Imaging Closes Oversubscribed $5 Million Series A Financing Round Led By Roadmap Capital

      Perimeter Medical Imaging, Inc., a developer of real time imaging systems for in-surgery tissue assessment, is pleased to announce the closing of their $5 million Series A financing. The round was led by Roadmap Capital with participation from EPIC Capital, NorthView Ventures and Pathfinder Asset Management. Funds will support the completion of their current clinical study at Princess Margaret Cancer Centre as well as product development and FDA regulatory clearance for their first tissue imaging product. Perimeter’s ground-breaking new Optical Tissue Imaging System (OTIS™) is an intraoperative medical imaging tool that provides clinicians with the ability to visualize the ...

      Read Full Article
    16. FedDev Ontario Supports Commercialization of Perimeter Medical Imaging’s OTIS™ Surgical Tissue Imaging System

      FedDev Ontario Supports Commercialization of Perimeter Medical Imaging’s OTIS™ Surgical Tissue Imaging System

      Perimeter Medical Imaging, Inc., a developer of real time imaging systems for in-surgery tumour margin assessment, today announced it is receiving up to $980,000 from the Government of Canada through the Federal Economic Development Agency for Southern Ontario (FedDev Ontario). The announcement was made at Perimeter’s new location in Toronto by John Carmichael, Member of Parliament for Don Valley West, on behalf of the Honourable Gary Goodyear, Minister of State for the Federal Economic Development Agency for Southern Ontario (FedDev Ontario). This investment will support the next phase of product and clinical development as well as accelerate regulatory ...

      Read Full Article
    17. Optovue Introduces AngioVue OCTA in Glaucoma

      Optovue Introduces AngioVue OCTA in Glaucoma

      Optovue, a pioneer in optical coherence tomography angiography (OCTA) and leader in commercialization of the technology, announced that it has expanded the application of its OCT Angiography technology into glaucoma. After a successful introduction of the revolutionary AngioVue Imaging System to retina last year, Optovue has worked to develop clinical applications in glaucoma as well.

      The use of the AngioVue Imaging System in glaucoma was introduced at a highly successful symposium at the 6th World Glaucoma Congress in Hong Kong. The Optovue-hosted event featured presentations on the clinical applications of OCTA in glaucoma research using the company's AngioVue OCTA ...

      Read Full Article
    18. Transformative clinical results with VivoSight in the diagnosis of Basal Cell Carcinoma: Data to be presented at the World Congress of Dermatology in Vancouver

      Transformative clinical results with VivoSight in the diagnosis of Basal Cell Carcinoma: Data to be presented at the World Congress of Dermatology in Vancouver

      Michelson Diagnostics, a medical device company focused on multi-beam Optical Coherence Tomography (‘OCT’) technology, today announces that data showing significant improvement in the diagnosis of basal-cell carcinoma (BCC) using its VivoSight multibeam OCT scanner will be presented at the World Congress of Dermatology (Vancouver, June 8-13). In addition to being an efficient, non-invasive way to diagnose BCC and other non-melanoma skin cancers, using the VivoSight OCT scanner has the potential to reduce biopsies and surgery, thereby reducing scarring for patients. Joint lead investigator, Dr Martina Ulrich, CMB Collegium, Berlin, Germany, will outline the results of this independent multi-centre, prospective clinical ...

      Read Full Article
    19. ZEISS Presents Its New Generation of Vascular Imaging: OCT Angiography

      ZEISS Presents Its New Generation of Vascular Imaging: OCT Angiography

      Nearly two decades ago, ZEISS was the first company to introduce optical coherence tomography (OCT) for clinical use in ophthalmology and optometry. The 20 presentations on OCT angiography by ZEISS and its research collaborators at this year’s ARVO meeting in May are testament to the company’s dedication to continued innovation and advancing the practice of medicine. ZEISS is developing OCT angiography for both spectral domain (SD) and swept source platforms. The OCT angiography application on the SD platform is currently under FDA review and is 510(k) pending. “The en face angiograms from the ZEISS SD-OCT angiography prototype ...

      Read Full Article
    20. Cataract Surgery and the LenSx® Femtosecond Laser System—2015 Update

      Cataract Surgery and the LenSx® Femtosecond Laser System—2015 Update

      Femtosecond laser-assisted cataract surgery continues to gain popularity as clinicians adopt the technology with the desire to improve the safety and efficacy of cataract surgery. The technology continues to evolve as clinical experience points to improvements to better meet the needs of surgeons and patients. The effect of these system updates, and the increasing body of experience with femtosecond laser systems, has reduced complication rates and seen the technology applied to more challenging cases. This article provides an updated review of the LenSx® femtosecond Laser system, including recent system modifications and the most- recent published literature. The LenSx® Laser system ...

      Read Full Article
      Mentions: LenSx
    21. Leica Microsystems to Acquire OCT Company Bioptigen

      Leica Microsystems to Acquire OCT Company Bioptigen

      Integration of Optical Coherence Tomography (OCT) Opens up New Avenues for Ophthalmology and Life Science Research Leica Microsystems, a global leader in microscopy and imaging systems, has signed a definitive agreement to acquire Bioptigen, Inc. to strengthen its position in the ophthalmology market. Bioptigen is a technology leader in the field of optical coherence tomography (OCT). The integration of OCT imaging into Leica Microsystems’ surgical microscopes will assist ophthalmologists during eye surgery. Bioptigen develops and manufactures innovative OCT systems and software and is globally successful with products for clinical as well as translational research applications. Using low-power, near-infrared light, Bioptigen ...

      Read Full Article
    22. New Data Further Emphasize the Clinical Benefits of St. Jude Medical’s OCT Technology

      New Data Further Emphasize the Clinical Benefits of St. Jude Medical’s OCT Technology

      St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, today announced preliminary results from the ILUMIEN I trial and final results from the ILUMIEN II clinical study. Taken together, the findings from both studies show that with resolution up to 10 times higher than intravascular ultrasound (IVUS), optical coherence tomography (OCT) imaging can help improve stent selection and deployment, better support clinical decision-making and improve patient outcomes. Data from both studies were presented today as late-breaking clinical trials at EuroPCR 2015, and further advance the use of OCT imaging alongside percutaneous coronary intervention (PCI). During PCI procedures, physicians ...

      Read Full Article
    23. Cambridge role in new medical device

      Cambridge role in new medical device

      VivoSight Dx is aimed at dermatologists seeking an imaging system that will enhance their ability to make rapid and accurate diagnostic decisions for their patients. Michelson Diagnostics approached eg technology to undertake the aesthetic and detailed design of the product trolley and enclosure and the assembly methodology of the functional elements of the OCT system. eg and Michelson worked with dermatologists who were already using the first generation OCT system in order to gain insight into how the machine was used and how the system could be developed to enhance the experience of both the user and the patient. From ...

      Read Full Article
    24. Avinger Announces 30-Day VISION Trial Results at EuroPCR 2015

      Avinger Announces 30-Day VISION Trial Results at EuroPCR 2015

      Avinger, Inc., (Nasdaq: AVGR ) a developer and manufacturer of image-guided, catheter-based systems for the treatment of peripheral arterial disease (PAD) and pioneer of the lumivascular approach to treating vascular disease, today announced 30-day interim results for its VISION clinical study. VISION is designed to evaluate the safety and efficacy of the Pantheris™ system to perform directional atherectomy, while for the first time ever allowing physicians to use real-time intravascular imaging to aid in the removal of plaque from diseased lower extremity arteries. Results were presented by Arne Schwindt, M.D. of St. Franziskus Hospital in Muenster, Germany at the EuroPCR ...

      Read Full Article
    73-96 of 1008 « 1 2 3 4 5 6 7 ... 40 41 42 »
  1. Categories

    1. Applications:

      Art, Cardiology, Dentistry, Dermatology, Developmental Biology, Gastroenterology, Gynecology, Microscopy, NDE/NDT, Neurology, Oncology, Ophthalmology, Other Non-Medical, Otolaryngology, Pulmonology, Urology
    2. Business News:

      Acquisition, Clinical Trials, Funding, Other Business News, Partnership, Patents
    3. Technology:

      Broadband Sources, Probes, Tunable Sources
    4. Miscellaneous:

      Jobs & Studentships, Student Theses, Textbooks
  2. Popular Articles

  3. People in the News

    1. (1 articles) Eric A. Swanson
  4. OCT Companies in the News

    1. (1 articles) Wasatch Photonics
    2. (1 articles) St. Jude Medical